文献速递银屑病与炎症性皮肤病

心血管-肾脏-代谢健康、遗传易感性与银屑病发病风险

Cardiovascular-kidney-metabolic health, genetic predisposition and incident risk of psoriasis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2025-07-18

基于英国生物银行392,454名无银屑病参与者的前瞻性队列研究,评估心血管-肾脏-代谢(CKM)综合征分期与遗传风险对银屑病发病及预期寿命的影响。结果显示CKM分期越高,银屑病风险越高,且与高遗传风险存在正向相加交互,晚期CKM与银屑病患者预期寿命缩短相关。

要点

  • CKM分期1-4期银屑病风险均高于0期,呈递增趋势。
  • CKM 4期且高遗传风险者银屑病风险最高(HR=2.82)。
  • 晚期CKM与高遗传风险对银屑病发病存在正向相加交互。

核心结论

  • CKM健康状况差与中老年人银屑病发病风险升高显著相关,高遗传风险者尤甚,且与银屑病患者预期寿命缩短相关。

研究设计与样本

  • 前瞻性队列研究,纳入英国生物银行392,454名无银屑病参与者,CKM综合征按代谢危险因素、慢性肾病和心血管病分为0-4期,遗传风险采用多基因风险评分评估,使用Cox比例风险回归模型估计风险比。

主要发现

  • 与CKM 0期相比,1、2、3、4期发生银屑病的多变量调整HR(95%CI)分别为1.21(1.06-1.38)、1.38(1.24-1.55)、1.64(1.42-1.91)和1.72(1.47-2.01)。
  • CKM 4期且高遗传风险者相比0期且低遗传风险者,银屑病风险最高(HR=2.82,95%CI:2.28-3.49)。
  • 晚期CKM与高遗传风险对银屑病发病存在显著正向相加交互(RERI=0.82,95%CI:0.35-1.32)。
  • 银屑病患者中,CKM 4期与预期寿命减少2.03年(95%CI:0.25-3.81年)相关。

临床怎么用

  • 对银屑病患者应评估CKM健康状况,晚期CKM患者需关注预期寿命缩短风险。
  • 高遗传风险且CKM状况差的中老年人应加强银屑病风险监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited evidence exists concerning the relationship between cardiovascular-kidney-metabolic (CKM) health and the incidence and prognosis of psoriasis. OBJECTIVES: This study aimed to evaluate the associations between CKM status, genetic risk and the risk of developing psoriasis, as well as to examine the impact of CKM syndrome on life expectancy in patients with psoriasis. METHOD: This prospective cohort study included 392,454 participants free of psoriasis from the UK Biobank. CKM syndrome was defined by the presence of metabolic risk factors, chronic kidney disease and cardiovascular disease, categorized into five stages (0-4). The genetic risk of psoriasis was assessed using a polygenic risk score. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for the incident risk of psoriasis. RESULTS: Compared to participants in stage 0, the multivariable-adjusted HRs (95% CIs) for developing psoriasis in individuals with CKM stages 1, 2, 3 and 4 were 1.21 (1.06-1.38), 1.38 (1.24-1.55), 1.64 (1.42-1.91) and 1.72 (1.47-2.01), respectively. Joint association analyses revealed that participants with CKM stage 4 and high genetic risk had the highest risk of psoriasis compared to those at stage 0 with low genetic risk (HR = 2.82, 95% CI: 2.28-3.49). Notably, there was a significant positive additive interaction between advanced CKM stages and high genetic risk in the development of psoriasis (RERI = 0.82, 95% CI: 0.35-1.32). Additionally, within the psoriasis population, advanced CKM stage (stage 4) was associated with a greater reduction in life expectancy (2.03 years, 95% CI: 0.25-3.81 years). CONCLUSIONS: Poor CKM health was significantly associated with a higher risk of psoriasis in midlife and older adults, particularly among those with high genetic risk and was further linked to decreased life expectancy among patients with psoriasis.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Zheng G, Zhang Y, Su H, et al. Cardiovascular-kidney-metabolic health, genetic predisposition and incident risk of psoriasis. J Eur Acad Dermatol Venereol. 2025. PMID: 40679132. doi:10.1111/jdv.20852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。